arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Becton, Dickinson and Company

BDX Health Care Medical/Dental Instruments
$184.54
▼ -0.1% Today
as of Sep 4, 16:46 ET
Last 30 days +16.25% Jul 27 → Sep 04
$156.27 $165.87 $175.46 $185.05 $194.65 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$185.42
High
$187.13
Low
$184.05
Volume
$1M
Avg Vol
$3M
Mkt Cap
$49.6B
P/E (TTM)
118.45
Beta
—
52w High
$193.07
52w Low
$127.59
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 25 ▼ 0
Sep 4 · 15:08 Barchart neutral
How Is Becton, Dickinson and Company's Stock Performance Compared to Other Medical Devices Stocks?
Sep 3 · 03:26 Simply Wall St. neutral
Becton Dickinson (BDX) Becomes Founding Sponsor Of Hazardous Drug Data Consortium
Aug 31 · 11:46 MT Newswires neutral
BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$128
$193
87% of range
Avg surprise (last 3)
+4.8%
Avg reaction (last 2)
-6.1%
50% positive
Latest IV / EM
25%
EM ±4.0% · $185 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.96$1.64$2.32$3.00$3.68 Actual $1.53Actual $1.36Actual $0.96Actual $1.85Actual $1.68Actual $1.04Actual $3.35Est $3.28Actual $3.68Est $3.42Actual $1.34Actual $2.90Est $2.77Actual $1.37 MarJunDecMarJunDecMar/2025Jun/2025DecMar/2026Jun
Revenue vs Net Income Revenue Net income
$-311M$1.1B$2.6B$4.1B$5.5B Dec 24Mar 25Jun 25Dec 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.37 — — — — financials
Thu May 7, 2026Mar/2026 $2.90 $2.77 +4.7% -13.4% +5.9% earnings
Wed Dec 31, 2025Dec 2025 $1.34 — — — — financials
Thu Aug 7, 2025Jun/2025 $3.68 $3.42 +7.6% — — earnings
Thu May 1, 2025Mar/2025 $3.35 $3.28 +2.1% — -18.1% earnings
Tue Dec 31, 2024Dec 2024 $1.04 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.68 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.85 — — — — financials
Sun Dec 31, 2023Dec 2023 $0.96 — — — — financials
Fri Jun 30, 2023Jun 2023 $1.36 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.53 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$4.98B$4.71B$5.25B—$4.73B$4.48B$5.17B—
Cost of revenue$2.67B$2.56B$2.84B—$2.49B$2.62B$2.93B—
Gross profit————————
Operating income$663M$93M$552M—$739M$383M$453M—
Net income$377M$-311M$382M—$574M$308M$303M—
EPS (diluted)$1.37$-1.11$1.34—$2.00$1.07$1.04—

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$708M$813M$740M$567M$735M$667M$711M$1.72B
Inventory$3.32B$3.36B$4.08B$3.15B$3.95B$3.72B$3.86B$3.84B
Total current assets$8.14B$8.01B$9.19B$9.26B$9.00B$8.67B$8.66B$10.47B
Total assets$50.73B$50.83B$54.84B$55.33B$54.90B$54.47B$54.66B$57.29B
Long-term debt$13.51B$14.71B$16.92B$17.62B$17.53B$17.67B$17.44B$17.94B
Total liabilities————————
Total equity$24.42B$24.13B$25.28B$25.39B$25.47B$25.24B$25.20B$25.89B

Implied volatility — last 90 days

22%32%41%50%59% Jun 07 — IV 30% · EM ±4.2%Jun 08 — IV 34% · EM ±4.5%Jun 09 — IV 35% · EM ±4.4%Jun 10 — IV 31% · EM ±3.7%Jun 11 — IV 37% · EM ±4.1%Jun 12 — IV 28% · EM ±2.9%Jun 15 — IV 38% · EM ±2.7%Jun 16 — IV 40% · EM ±2.3%Jun 17 — IV 54% · EM ±2.3%Jun 19 — IV 25% · EM ±5.6%Jun 22 — IV 28% · EM ±5.9%Jun 23 — IV 29% · EM ±5.8%Jun 24 — IV 29% · EM ±5.8%Jun 25 — IV 30% · EM ±5.9%Jun 26 — IV 28% · EM ±5.3%Jun 29 — IV 23% · EM ±4.2%Jun 30 — IV 27% · EM ±4.7%Jul 01 — IV 27% · EM ±4.5%Jul 02 — IV 27% · EM ±4.4%Jul 03 — IV 28% · EM ±4.4%Jul 06 — IV 28% · EM ±3.9%Jul 07 — IV 25% · EM ±3.3%Jul 08 — IV 28% · EM ±3.5%Jul 09 — IV 33% · EM ±3.8%Jul 10 — IV 27% · EM ±2.9%Jul 13 — IV 34% · EM ±2.8%Jul 14 — IV 31% · EM ±2.2%Jul 15 — IV 42% · EM ±2.5%Jul 16 — IV 46% · EM ±1.9%Jul 20 — IV 34% · EM ±8.1%Jul 21 — IV 34% · EM ±7.9%Jul 22 — IV 36% · EM ±8.2%Jul 23 — IV 35% · EM ±8.0%Jul 24 — IV 35% · EM ±7.8%Jul 27 — IV 36% · EM ±7.6%Jul 28 — IV 41% · EM ±8.4%Jul 29 — IV 37% · EM ±7.5%Jul 30 — IV 37% · EM ±7.2%Jul 31 — IV 38% · EM ±7.3%Aug 03 — IV 40% · EM ±7.0%Aug 04 — IV 45% · EM ±7.8%Aug 05 — IV 47% · EM ±7.9%Aug 06 — IV 32% · EM ±5.1%Aug 07 — IV 29% · EM ±4.6%Aug 10 — IV 28% · EM ±3.8%Aug 11 — IV 29% · EM ±3.8%Aug 12 — IV 26% · EM ±3.3%Aug 13 — IV 27% · EM ±3.1%Aug 14 — IV 29% · EM ±3.2%Aug 17 — IV 29% · EM ±2.4%Aug 18 — IV 31% · EM ±2.2%Aug 19 — IV 37% · EM ±2.2%Aug 20 — IV 60% · EM ±2.5%Aug 24 — IV 26% · EM ±5.5%Aug 25 — IV 25% · EM ±5.2%Aug 26 — IV 24% · EM ±4.9%Aug 27 — IV 26% · EM ±5.2%Aug 28 — IV 23% · EM ±4.4%Aug 31 — IV 26% · EM ±4.7%Sep 01 — IV 23% · EM ±4.0%Sep 02 — IV 28% · EM ±4.7%Sep 03 — IV 26% · EM ±4.1%Sep 04 — IV 25% · EM ±4.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in